About this episode

The episode discusses advances in osteoporosis care, including the SABRE initiative and the role of AI in fracture prediction.

On this episode of Bone Talk, BHOF CEO Claire Gill is joined by Dr. Mary Bouxsein, Professor at Harvard Medical School and a leading researcher in bone health and biomechanics, to discuss groundbreaking advances that could transform osteoporosis care. Their conversation explores how the SABRE initiative is reshaping osteoporosis drug development, the growing role of artificial intelligence in fracture prediction and screening, and why greater awareness and participation in research are essential to improving bone health outcomes for millions of people.

People in this episode

Host: Claire Gill

Guest: Dr. Mary Bouxsein

Topics covered

• osteoporosis research
• bone health
• artificial intelligence
• drug development
• fracture prediction
• biomechanics

Keywords

• osteoporosis
• bone health
• SABRE
• AI
• fracture prediction
• biomechanics
• research

Mentioned in this episode

Organizations: Harvard Medical School, Bone Health & Osteoporosis Foundation, SABRE

Explore listener stats, chart rankings, contacts and more on the Bone Talk podcast page.